Google’s Gemma-based C2S-Scale model helped Yale find a drug combo that boosts tumor antigen presentation, pointing to a new ...

Google's open-source AI model has developed a potential therapy for cancer by suggesting new drug candidates, including ...

This foundation model has not only decoded cellular language but has also generated and experimentally validated a new ...

New research has identified markers of two critical stem cell populations that drive colorectal cancer formation.

Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or ...

The hypothesis was generated by a 27-billion-parameter foundation model called Cell2Sentence-Scale 27B (C2S-Scale), developed by researchers at Google DeepMind and Yale University. Built on Google's ...

Scale” model spotted a drug combination that made tumors more visible to the immune system, a breakthrough Google calls “a ...

Google’s C2S-Scale 27B foundation model, developed in partnership with Yale University and based on the Gemma framework, has ...

German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round ...

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a ...

Kolon Life Science announced that it will present the preclinical research results of its next-generation anticancer gene ...